Alignment Healthcare closed at $8.14 on Nov 4, up 10.15%, 66.9% below its 52-week closing high. Volume of 5.6M shares was 0.72× its 20-day average (below normal).
Split-adjusted performance: -2.7% over one month, -55.1% over six months, -51.7% over one year.
In the quarter ended Sep 30, 2026, revenue was $1.35B, up 37.1% from a year earlier, with a net margin of -0.6%.
Short interest was 25.5M shares at the Oct 15 settlement, up 8.1% from the prior report (14.0% of float, 2.2 days to cover).